Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

At the University of Illinois, we’ve discovered that faith and science, united through dialogue and understanding, is our pathway to connect.

Scientists have successfully created immature human egg-like cells from skin-derived stem cells, a significant step in ...

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

NASA-funded researcher Dorit Donoviel is leading efforts to design autonomous healthcare systems for astronauts on deep space missions.

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

In a nascent and fragmented regulatory environment, focusing on the ethical implications of the company’s AI activities is a prudent strategy for board oversight of AI risk.

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...